BioLife Solutions Inc

General ticker "BLFS" information:

  • Sector: Health Care
  • Industry: Life Sciences Tools & Services
  • Capitalization: $1.2B

BioLife Solutions Inc follows the US Stock Market performance with the rate: 64.5%.

Estimated limits based on current volatility of 4.9%: low 25.29$, high 27.89$

Factors to consider:

  • Current price 21.5% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [9.90$, 22.54$]
  • 2024-12-30 to 2025-12-30 estimated range: [11.29$, 24.49$]

Financial Metrics affecting the BLFS estimates:

  • Negative: Non-GAAP EPS, $ of -1.52 <= 0.10
  • Negative: Operating profit margin, % of -33.08 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -2.00 <= 2.35
  • Positive: Interest expense per share, $ of 0.04 <= 0.14

Similar symbols

Short-term BLFS quotes

Long-term BLFS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $119.16MM $161.76MM $143.27MM
Operating Expenses $154.32MM $307.30MM $214.10MM
Operating Income $-35.16MM $-145.54MM $-70.83MM
Non-Operating Income $6.13MM $0.71MM $4.57MM
Interest Expense $0.48MM $0.69MM $1.81MM
R&D Expense $11.82MM $14.80MM $18.80MM
Income(Loss) $-29.03MM $-144.83MM $-66.26MM
Taxes $-20.12MM $-5.02MM $0.17MM
Profit(Loss) $-8.91MM $-139.81MM $-66.43MM
Stockholders Equity $478.05MM $364.19MM $337.66MM
Inventory $28.34MM $34.90MM $43.46MM
Assets $554.29MM $450.23MM $412.71MM
Operating Cash Flow $-4.84MM $-8.49MM $-12.50MM
Capital expenditure $8.38MM $10.38MM $6.38MM
Investing Cash Flow $-12.64MM $-58.12MM $17.84MM
Financing Cash Flow $-2.78MM $16.32MM $10.59MM
Earnings Per Share* $-0.22 $-3.29 $-1.52

* EPS are Split Adjusted, recent splits may be reflected with a delay.